NCT02206620 Effects of Cholinergic Augmentation on Measures of Balance and Gait Status COMPLETED Phase PHASE2
NCT02190851 Transcutaneous Electrical Nerve Stimulation (TENS) for Lower Urinary Tract Disorders in Parkinson's Syndrome Status COMPLETED Phase NA
NCT02184546 Outcomes Data of Adipose Stem Cells to Treat Parkinson's Disease Status UNKNOWN Phase N/A
NCT02184494 Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients Status COMPLETED Phase NA
NCT02183519 Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02174250 The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT02168504 Electromyography Signals as Biomarkers for Parkinson's Disease Status COMPLETED Phase N/A
NCT02164162 Efficacy of a Robotic-assisted Gait Training in Addition to a Conventional Physical Therapy in Parkinson's Disease Status UNKNOWN Phase NA
NCT02162979 Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease Status TERMINATED Phase PHASE2
NCT02157714 Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02153645 Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. Status TERMINATED Phase PHASE3
NCT02153632 Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID Status TERMINATED Phase PHASE3
NCT02152319 Automated Telehealth Diagnostics for Remote Parkinson Monitoring Status COMPLETED Phase NA
NCT02136914 ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) Status COMPLETED Phase PHASE3
NCT02134795 A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease Status TERMINATED Phase NA
NCT02125825 Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration Status COMPLETED Phase N/A